InsidersTradesSigma
Zealand Pharma A/S Stock: price and directors' dealings · Denmark · Finanstilsynet DK
Track the Zealand Pharma A/S share price and the full directors' dealings record of the company, a listed equity based in Denmark. Shares are quoted on DK DK, under the authority of Finanstilsynet DK. Operating in the Healthcare & Pharma sector, Zealand Pharma A/S has recorded 57 reports. Market capitalisation: €20.8bn. The latest transaction was reported on 22 June 2026 (Sale). Among the most active insiders: Unknown. The full history is openly available.
57
Insider Decl.
0
Thresholds
€341,229
5 ops.
Buy Volume
€6m
17 ops.
Sell Volume
25Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 6 of 26,212 companies
97.3
score / 100
Value98
Quality97
FCF yld33%
Earn yld32%
EV/EBITDA2.9x
ROE56%
Gross mgn100%
Net mgn70%
Debt/EBITDA0.1x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 22 June 2026
Declarations57 total
1,000 shares@ DKK 278.000.0002% mcap14.0% of flowShareNasdaq Copenhagen, XCSEDK:1449295
4,547 shares@ DKK 90.700.0003% mcap24.2% of flowShareOutside a trading venue, XOFFDK:1447494
4,000 shares@ DKK 322.800.0008% mcap100.0% of flowShareOutside a trading venue, XOFFDK:1445443
29,403 shares@ DKK 316.29060.0057% mcap2.6% of flowShareOutside a trading venue, XOFFDK:1436237
1,500 shares@ DKK 329.300.0003% mcap0.1% of flowShareOutside a trading venue, XOFFDK:1435190
1 shares@ DKK 467.000.0000% mcap0.0% of flowShareNasdaq Copenhagen, XCSEDK:1407692
15,442 shares@ DKK 487.600.0046% mcap2.1% of flowShareOutside a trading venue, XOFFDK:1404877
106,680 shares@ DKK 408.900.027% mcap12.3% of flowShareOutside a trading venue, XOFFDK:1366074
1,217 shares@ DKK 424.500.0003% mcap0.1% of flowShareOutside a trading venue, XOFFDK:1356822
1,090 shares0ShareOutside a trading venue, XOFFDK:1337157
ShareDK:1335333
1,000 shares@ DKK 850.000.0005% mcap0.2% of flowShareNasdaq Copenhagen (OMX)DK:1327123
35,000 shares@ DKK 878.000.019% mcap8.7% of flowShareNasdaq CopenhagenDK:1314117
12 shares0.13% mcap57.9% of flowShareOutside trading VenueDK:1294926
8,008 shares@ DKK 598.000.0029% mcap1.3% of flowShareOutside the marketDK:1289217
854 shares@ DKK 598.000.0003% mcap0.1% of flowShareOutside the marketDK:1289173
2,000 shares@ DKK 712.000.0009% mcap0.4% of flowShareNasdaq CopenhagenDK:1284047
500 shares@ DKK 699.000.0002% mcap0.1% of flowShareNasdaq CopenhagenDK:1282221
1,000 shares@ DKK 739.000.0005% mcap0.2% of flowShareNasdaq CopenhagenDK:1280108
8,401 shares@ DKK 138.600.0007% mcap0.3% of flowShareOutside trading venueDK:1279394
1,800 shares@ DKK 351.110.0004% mcap0.2% of flowShareNasdaq CopenhagenDK:1263706
Ideal exit: 2 Sept 2024 (T+270)
2 shares@ DKK 3,399,409.000.0042% mcap1.9% of flowShareOutside trading VenueDK:1262781
1,500 shares@ DKK 224.400.0002% mcap0.1% of flowShareOutside trading venueDK:1247975
2,035 shares@ DKK 264.600.0003% mcap0.2% of flowShareNasdaq CopenhagenDK:1245819
3,000 shares@ DKK 268.61860.0005% mcap0.2% of flowShareNasdaq CopenhagenDK:1244689
25 of 57 declarations
About Zealand Pharma A/S
Zealand Pharma A/S is a Danish biopharmaceutical company focused on developing treatments for metabolic and endocrine diseases. It emphasizes innovation in the field of therapeutic peptides.
